• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

决策者需要一种方法来确定数字治疗产品的质量、可及性和适当使用。

Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use.

机构信息

Xcenda, AmerisourceBergen, Palm Harbor, FL.

Digital Therapeutics Alliance, Arlington, VA.

出版信息

J Manag Care Spec Pharm. 2021 Apr;27(4):536-538. doi: 10.18553/jmcp.2021.27.4.536.

DOI:10.18553/jmcp.2021.27.4.536
PMID:33769855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391241/
Abstract

No funding was received for the writing of this article. Parcher is employed by Xcenda and has nothing to disclose. Coder is employed by Digital Therapeutics Alliance, which is a member of the USP Convention. Coder reports fees from PsychU/Otsuka.

摘要

本文撰写没有接受任何资助。Parcher 受雇于 Xcenda，没有任何需要披露的事项。Coder 受雇于 Digital Therapeutics Alliance，该组织是 USP 大会的成员。Coder 从 PsychU/Otsuka 获得酬金。

相似文献

1
Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use.决策者需要一种方法来确定数字治疗产品的质量、可及性和适当使用。
J Manag Care Spec Pharm. 2021 Apr;27(4):536-538. doi: 10.18553/jmcp.2021.27.4.536.
2
Ensuring public trust in digital therapeutics: a pharmacopeial perspective.确保公众对数字疗法的信任：一个药典的视角。
J Manag Care Spec Pharm. 2021 Apr;27(4):533-535. doi: 10.18553/jmcp.2021.27.4.533.
3
Methodology for conducting a comprehensive product review in managed care.在托管式医疗中进行全面产品审查的方法。
J Manag Care Spec Pharm. 2023 Mar;29(3):237-243. doi: 10.18553/jmcp.2023.29.3.237.
4
Can We Trust the Quality of Generic Drugs?我们能相信仿制药的质量吗？
J Manag Care Spec Pharm. 2020 May;26(5):589-591. doi: 10.18553/jmcp.2020.26.5.589.
5
Is the Quality of Generic Drugs Cause for Concern?仿制药的质量是否令人担忧？
J Manag Care Spec Pharm. 2020 May;26(5):597-599. doi: 10.18553/jmcp.2020.26.5.597.
6
A Physician's Perspective on Generic Drug Quality.医生视角下的仿制药质量。
J Manag Care Spec Pharm. 2020 May;26(5):592-593. doi: 10.18553/jmcp.2020.26.5.592.
7
The Reemergence of Specialty Pharmacy.专科药房的再现。
J Manag Care Spec Pharm. 2020 Mar;26(3):234-235. doi: 10.18553/jmcp.2020.26.3.234.
8
Indication or diagnosis should be required on prescriptions.处方上应注明适应证或诊断。
J Manag Care Spec Pharm. 2021 Aug;27(8):1136-1139. doi: 10.18553/jmcp.2021.27.8.1136.
9
Moving Pharmacy Benefits from Nice to Have to Essential Benefits.将药房福利从可有可无转变为必不可少的福利。
J Manag Care Spec Pharm. 2020 Aug;26(8):943-944. doi: 10.18553/jmcp.2020.26.8.943.
10
AMCP Partnership Forum: The evolving role of digital therapeutics.AMCP 合作论坛：数字疗法的不断演变的角色。
J Manag Care Spec Pharm. 2022 Jul;28(7):804-810. doi: 10.18553/jmcp.2022.22093. Epub 2022 Jun 14.

引用本文的文献

1
Considerations for US coverage and reimbursement: Which digital health products to evaluate? Findings from a modified Delphi study.美国医保覆盖范围及报销的考量因素：应评估哪些数字健康产品？一项改良德尔菲研究的结果
J Manag Care Spec Pharm. 2024 Aug;30(8):854-859. doi: 10.18553/jmcp.2024.30.8.854.
2
Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectives.数字疗法保险覆盖范围的洞察：对美国支付方观点的定性研究。
J Manag Care Spec Pharm. 2024 Apr;30(4):313-325. doi: 10.18553/jmcp.2024.30.4.313.
3
Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework.采用证据DEFINED框架对数字健康进行严格快速的证据评估。
NPJ Digit Med. 2023 May 31;6(1):101. doi: 10.1038/s41746-023-00836-5.
4
Development of a Digital Healthcare Management System for Lower-Extremity Amputees: A Pilot Study.下肢截肢者数字医疗管理系统的开发：一项试点研究。
Healthcare (Basel). 2022 Dec 29;11(1):106. doi: 10.3390/healthcare11010106.
5
AMCP Partnership Forum: The evolving role of digital therapeutics.AMCP 合作论坛：数字疗法的不断演变的角色。
J Manag Care Spec Pharm. 2022 Jul;28(7):804-810. doi: 10.18553/jmcp.2022.22093. Epub 2022 Jun 14.
6
The good, the bad, and the poorly designed: The mobile app stores are not a user-friendly experience for health and medical purposes.有好的、有坏的，还有设计糟糕的：移动应用商店在健康和医疗用途方面并非用户友好的体验。
Digit Health. 2022 Apr 5;8:20552076221090038. doi: 10.1177/20552076221090038. eCollection 2022 Jan-Dec.
7
Ensuring public trust in digital therapeutics: a pharmacopeial perspective.确保公众对数字疗法的信任：一个药典的视角。
J Manag Care Spec Pharm. 2021 Apr;27(4):533-535. doi: 10.18553/jmcp.2021.27.4.533.

本文引用的文献

1
AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits?AMCP 合作论坛：数字疗法——它们是什么，以及它们在药学和医疗福利中的定位是什么？
J Manag Care Spec Pharm. 2020 May;26(5):674-681. doi: 10.18553/jmcp.2020.19418. Epub 2020 Mar 16.
2
Computer-based cognitive training for ADHD: a review of current evidence.注意力缺陷多动障碍的计算机化认知训练：当前证据综述
Child Adolesc Psychiatr Clin N Am. 2014 Oct;23(4):807-24. doi: 10.1016/j.chc.2014.05.009. Epub 2014 Aug 10.
3
Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes.旨在训练工作记忆、其他执行功能和注意力的项目是否有益于患有 ADHD 的儿童？认知、学业和行为结果的元分析综述。
Clin Psychol Rev. 2013 Dec;33(8):1237-52. doi: 10.1016/j.cpr.2013.08.005. Epub 2013 Aug 24.